Sean Fullerton, M.D., specializes in Benign Prostatic Hyperplasia (BPH), obstructive uropathy, complex urinary stones, bladder dysfunction in men and women, kidney obstruction, and prostatitis. He supervises the resident clinic run weekly at Westchester Medical Center. In this respect, Dr. Fullerton ensures that residents build their own ‘patient panels’ and practice a continuity of care that will prove invaluable. He trains the residents in urodynamics, office cystoscopy, prostate biopsy, and ambulatory surgery.

Education

• M.D., State University of New York Medical University
• Residency, General Surgery, Lincoln Medical & Mental Health Center
• Residency, Urology, Westchester County Medical Center

Honors and Awards

• Top Doctor Award during Metropolitan Annual Medical Board Award Ceremony, 2016

Research

Dr. Fullerton serves as the P.I. of a prospective research study involving “Use of Thulium Laser in Urology”. This study will be conducted at WMC and MHC. Aside from Dr. Fullerton, Drs. Majid Eshghi at WMC and Dr. Sameh Naim at MHC will be involved in this prospective study. Dr. Fullerton will serve as Co-PI of two other studies (PCNL/Ureteroscopy) with Dr. Eshghi and Dr. Naim.

Publications

• Dusic EJ, Powers LN, Clowes Candadai SV, et. al. "Policy and laboratory practice: How quality control procedures for genetic testing perpetuate biological essentialism and discrimination against transgender, gender diverse, and intersex people." Journal of genetic counseling, (), (2024) . doi: 10.1002/jgc4.1925
• Lewis ACF, Chisholm RL, Connolly JJ, et. al. "Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network." American journal of human genetics, 111(6), (2024) 999-1005. doi: 10.1016/j.ajhg.2024.04.005
• Stenton SL, O'Leary MC, Lemire G, et. al. "Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project." Human genomics, 18(1), (2024) 44. doi: 10.1186/s40246-024-00604-w
• Madden EB, Hindorff LA, Bonham VL, et. al. "Advancing genomics to improve health equity." Nature genetics, 56(5), (2024) 752-757. doi: 10.1038/s41588-024-01711-z
• Fullerton SM, Brothers KB. "Expanding Applications of Clinical Genetic Testing - Ethical Challenges." The New England journal of medicine, 390(15), (2024) 1349-1351. doi: 10.1056/NEJMp2311466
• Dahlquist J, Robinson JO, Daoud A, et. al. "Public Perspectives on Investigative Genetic Genealogy: Findings from a National Focus Group Study." AJOB empirical bioethics, (), (2024) 1-11. doi: 10.1080/23294515.2024.2336904
• Hu J, Korchina V, Zouk H, et. al. "Genetic sex validation for sample tracking in next-generation sequencing clinical testing." BMC research notes, 17(1), (2024) 62. doi: 10.1186/s13104-024-06723-w

View All Publications

Memberships and Affiliations

• American Urological Association
• NYS, AUA
• Board of Advisers, Diversified Community Health Services, Inc.
• American Cancer Society
• Admissions Committee, NYMC
• CCC, Clinical Committee
• Surgical Performance Improvement Committee, MHC
• PEC, NYMC
• Annual Program Review Committee
• Resident Selection Committee

Teaching Responsibilities

As the Director of Ambulatory Care Urology at WMC, Dr. Fullerton provides outstanding teaching, mentoring, and supervisory services to all rotating medical students, residents, and fellows. In this weekly urology, clinic trainees have the opportunity of longitudinal follow-ups of patients. As a senior attending in the Department of Urology, he provides supervisory and teaching services to trainees in the in-patient setting at WMC.

Similarly at MHC, Dr. Fullerton provides excellent teaching, mentoring and supervisory services to medical students and residents. He is scheduled to give two talks at the Grand Rounds conference in this academic year.